Quantum-Si/$QSI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Quantum-Si

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Ticker

$QSI
Primary listing

Industry

Life Sciences Tools and Services

Employees

149

ISIN

US74765K1051

Quantum-Si Metrics

BasicAdvanced
$367M
-
-$0.66
2.75
-

What the Analysts think about Quantum-Si

Analyst ratings (Buy, Hold, Sell) for Quantum-Si stock.

Bulls say / Bears say

Quantum-Si's recent partnership with Avantor is expected to bolster sales in the biopharma sector, enhancing market reach and revenue potential. (TipRanks)
The company reported that ex-US revenues made up nearly 85% of the total revenues for Q1 2025, indicating strong international growth potential. (TipRanks)
Analysts have issued a 'Buy' rating with a $5.50 price objective, reflecting confidence in the company's future performance. (Defense World)
Quantum-Si reported total revenues of $808K, lower than the consensus estimated revenue of $960K for Q1 2025, indicating potential challenges in meeting revenue expectations. (TipRanks)
The company announced a 23% workforce reduction as part of a restructuring plan, which may signal internal challenges and could impact operational efficiency. (FastBull)
Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock, totaling approximately $11.71 million, which might raise concerns about insider confidence. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.

Quantum-Si Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Quantum-Si Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $QSI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs